In addition, SGLT2 inhibition prevents the development of abdominal aortic aneurysm in mice by limiting inflammation and MMP-2/9 expression by targeting specific upstream signaling pathways. The gene discussed is SLC5A2; the disease is abdominal aortic aneurysm.